We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This document explains the NHS view on private screening for different conditions and diseases.
The profiles provide an overview of data on cardiovascular and cardiovascular related conditions of heart disease, stroke, diabetes and kidney disease. Data will be available for England, integrated care boards and upper tier local authorities where available.
You should take caution when you use NSAIDs in patients with renal impairment or are at risk.
Abattoirs in the Pig Carcase Grading Scheme must abide by the regulations for dressing, weighing, grading and marking carcases.
Product Recall for H&M clasp beaded bracelet presenting a chemical risk.
The characteristics, diagnosis, epidemiology of hantaviruses.
Zoledronic acid is associated with reports of renal impairment and renal failure, especially in patients with pre-existing renal dysfunction or other risk factors. Renal function should be measured before each dose, and patients should be adequately hydrated before treatment. Renal...
Information on the programme, including commissioning, quality assurance, education and training.
Update of cardiovascular disease (CVD) profile indicators for heart disease, diabetes, kidney disease and stroke data for commissioning organisations.
Employers guide to assessing fitness to work, including asking for medical evidence, fit notes, and dealing with long term or frequent absences.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.